Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Reduction of interstitial fluid pressure after TNF-alpha treatment of three human melanoma xenografts.

Literature DB >> 8761366

Reduction of interstitial fluid pressure after TNF-alpha treatment of three human melanoma xenografts.

C A Kristensen¹, M Nozue, Y Boucher, R K Jain.

Abstract

Tumour necrosis factor-alpha (TNF-alpha) reduced the interstitial fluid pressure (IFP) to 54-64% (P < 0.05) and the mean arterial blood pressure (MABP) to 70% (P < 0.01) of control values after 5 h in three human melanoma tumour lines transplanted to nude mice.

Entities: Disease Gene Species

Mesh：

Substances：

Year: 1996 PMID： 8761366 PMCID： PMC2074665 DOI： 10.1038/bjc.1996.397

Source DB: PubMed Journal: Br J Cancer ISSN： 0007-0920 Impact factor: 7.640

17 in total

1. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.

Authors: D Lienard; P Ewalenko; J J Delmotte; N Renard; F J Lejeune
Journal: J Clin Oncol Date: 1992-01 Impact factor: 44.544

2. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.

Authors: K J Tracey; Y Fong; D G Hesse; K R Manogue; A T Lee; G C Kuo; S F Lowry; A Cerami
Journal: Nature Date: 1987 Dec 17-23 Impact factor: 49.962

3. The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors.

Authors: I C Kettelhut; W Fiers; A L Goldberg
Journal: Proc Natl Acad Sci U S A Date: 1987-06 Impact factor: 11.205

4. Tumor-necrosis factor can enhance radio-antibody uptake in human colon carcinoma xenografts by increasing vascular permeability.

Authors: S Folli; A Pèlegrin; Y Chalandon; X Yao; F Buchegger; D Lienard; F Lejeune; J P Mach
Journal: Int J Cancer Date: 1993-03-12 Impact factor: 7.396

5. NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide.

Authors: R G Kilbourn; S S Gross; A Jubran; J Adams; O W Griffith; R Levi; R F Lodato
Journal: Proc Natl Acad Sci U S A Date: 1990-05 Impact factor: 11.205

6. Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo.

Authors: A Asher; J J Mulé; C M Reichert; E Shiloni; S A Rosenberg
Journal: J Immunol Date: 1987-02-01 Impact factor: 5.422

7. Time-dependent behavior of interstitial fluid pressure in solid tumors: implications for drug delivery.

Authors: P A Netti; L T Baxter; Y Boucher; R Skalak; R K Jain
Journal: Cancer Res Date: 1995-11-15 Impact factor: 12.701

8. Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse.

Authors: Y Boucher; R K Jain
Journal: Cancer Res Date: 1992-09-15 Impact factor: 12.701

9. Interstitial fluid pressure in human melanoma xenografts. Relationship to fractional tumor water content, tumor size, and tumor volume-doubling time.

Authors: I Tufto; E K Rofstad
Journal: Acta Oncol Date: 1995 Impact factor: 4.089

10. Interstitial hypertension in superficial metastatic melanomas in humans.

Authors: Y Boucher; J M Kirkwood; D Opacic; M Desantis; R K Jain
Journal: Cancer Res Date: 1991-12-15 Impact factor: 12.701

21 in total

1. Effects of the tumor vasculature targeting agent NGR-TNF on the tumor microenvironment in murine lymphomas.

Authors: H W M van Laarhoven; G Gambarota; A Heerschap; J Lok; I Verhagen; A Corti; S Toma; C Gallo Stampino; A van der Kogel; C J A Punt
Journal: Invest New Drugs Date: 2006-01 Impact factor: 3.850

2. Immuno-PET of undifferentiated thyroid carcinoma with radioiodine-labelled antibody cMAb U36: application to antibody tumour uptake studies.

Authors: Marc-André Fortin; Alexei V Salnikov; Marika Nestor; Nils-Erik Heldin; Kristofer Rubin; Hans Lundqvist
Journal: Eur J Nucl Med Mol Imaging Date: 2007-02-03 Impact factor: 9.236

Review 3. Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor.

Authors: Yinghuan Li; Jie Wang; M Guillaume Wientjes; Jessie L-S Au
Journal: Adv Drug Deliv Rev Date: 2011-05-03 Impact factor: 15.470

4. Combination of Gold Nanoparticle-Conjugated Tumor Necrosis Factor-α and Radiation Therapy Results in a Synergistic Antitumor Response in Murine Carcinoma Models.

Authors: Nathan A Koonce; Charles M Quick; Matthew E Hardee; Azemat Jamshidi-Parsian; Judith A Dent; Giulio F Paciotti; Dmitry Nedosekin; Ruud P M Dings; Robert J Griffin
Journal: Int J Radiat Oncol Biol Phys Date: 2015-07-26 Impact factor: 7.038